About Us
Revolutionizing healthcare through accessible biosimilars
At Aspergen Inc. we are dedicated to revolutionizing healthcare by developing high-quality biosimilars that provide safe, effective, and accessible treatment options to patients globally. With a deep commitment to improving patient access to life-changing therapies, we combine cutting-edge science, intensive research, and regulatory expertise to deliver innovative biosimilar solutions.
Who We Are
Aspergen Inc. (a joint venture between Cipla and Kemwell Biopharma) is an emerging biopharmaceutical company specializing in the development, manufacturing, and commercialization of biosimilar products.
The partnership leverages Cipla and Kemwell’s complementary strengths for end-to-end product development, clinical development, regulatory filings, manufacturing and commercialization of biopharmaceutical products. Cipla combined with Kemwell’s expertise in biologics will accelerate bringing these essential products to market.
With a team of experienced scientists, researchers, and industry professionals, we are at the forefront of the biosimilars revolution, striving to address the medical needs of patients worldwide.
Our Commitment
Scientific Excellence
We have assembled a world-class team of scientists and researchers who possess extensive knowledge and expertise in biosimilar development. Through continuous innovation, state-of-the-art technologies, and collaboration with leading academic and industry partners, we aim to push the boundaries of biosimilar science and redefine the future of healthcare.
Global Accessibility
Our mission is to ensure that patients worldwide can benefit from the advantages of biosimilar therapies. We actively pursue partnerships and alliances to expand our reach, increase availability, and improve access to our biosimilar products in diverse markets. We work closely with healthcare providers, payers, and regulatory authorities to navigate complex landscapes and enable timely access to cost-effective treatments.
Archives
Categories
Copyright © 2025 Aspergen Inc.
